Arkansas Democrat-Gazette

Flooding shuts Abbott baby formula factory again

- LAURA REILEY AND TIMOTHY BELLA

Abbott Nutrition has again halted production at the Michigan plant that helped drive a nationwide baby formula shortage after storms pummeled the region and caused widespread flooding.

In a statement issued late Wednesday, the company said it stopped producing EleCare and other specialty and metabolic formulas after severe thundersto­rms Monday caused power failures and flood damage in and around Sturgis, Mich. Abbott — which restarted the Sturgis plant less than two weeks ago after a months-long closure helped trigger the crisis — said heavy rain overwhelme­d the city’s storm water system, flooding parts of the city, “including areas of our plant.”

“As a result, Abbott has stopped production of its EleCare specialty formula that was under way to assess damage caused by the storm and clean and re-sanitize the plant,” the company said in a statement.

Abbott noted it had informed the Food and Drug Administra­tion of the factory closure — days after the agency signed off on its reopening — and that it would “conduct comprehens­ive testing in conjunctio­n with the independen­t third party to ensure the plant is safe to resume production.”

“This will likely delay production and distributi­on of new product for a few weeks,” Abbott said.

Blame for the national shortage has fallen fairly equally on Abbott and the FDA, with its commission­er, Robert Califf, getting raked over the coals by policymake­rs in several congressio­nal hearings in recent weeks.

On Thursday morning, in a Senate hearing about the pandemic, Sen. Patty Murray, D-Wash., asked Califf about the flooding that forced Abbott’s infant formula manufactur­ing facility in Sturgis offline and what action the agency was taking in response.

“We have twice-daily intensive calls about all the work on the infant formula issue,” Califf said. “And at the end of the call yesterday, I commented it was one of the first days that we hadn’t had any surprises. Twenty minutes later, the email came cross about the flood in Sturgis.”

He assured parents and caregivers that the government is working to have sufficient product to meet demand.

“We had hoped to have a super supply so that we get the shelves completely restocked. The estimate is perhaps two weeks, but it’s too early to give an exact estimate of what the delay will be in the Sturgis plant,” he said.

Abbott said the delay should not worsen the shortage because there was “ample existing supply,” noting that it had produced 8.7 million pounds of infant formula in June for the U.S., the equivalent of 168.2 million 6 oz. feedings. A spokespers­on said that represente­d 95% of Abbott’s output before a February product recall and the Sturgis plant closure.

Abbott resumed production after meeting requiremen­ts specified by a May consent decree with the FDA, which included, among other things, obtaining an independen­t expert to review operations and compliance with the law.

“While this is an unfortunat­e setback and a reminder that natural weather events can also cause unforeseen supply chain disruption­s, I want to reassure consumers the all-of-government work to increase supply means we’ll have more than enough product to meet current demand,” Califf tweeted on Wednesday night. “We know Abbott is working quickly to assess the damage and will be reporting its progress to us in the days ahead. Once the company establishe­s a plan, FDA will be back in the facility working to ensure that they can restart producing safe and quality formula products quickly.”

The closure comes about a week after newly released documents showed the FDA had investigat­ed reports that as many as nine children had died since early 2021 after consuming baby formula produced at the Sturgis plant — seven more than previously acknowledg­ed by the FDA.

In all nine incidents, the agency was unable to identify the source of the infection. In some cases, there was not enough leftover formula to test. Of the babies who died of cronobacte­r infections, genomic sequencing turned up different strains than what was discovered during an inspection this spring.

Newspapers in English

Newspapers from United States